GLP-1
Retatrutide: The Triple Agonist GLP-1 Peptide Redefining Weight Loss in 2026
Retatrutide (LY3437943) is a triple GLP-1/GIP/glucagon receptor agonist showing 28.7% weight loss in Phase 3 — rivaling bariatric surgery. Here is everything you need to know.